Martha Stewart, the media maven who combined a talent for peddling 'good taste' with razor-sharp business acumen (at the apex of her career she was a director of the New York Stock Exchange), has been denied a retrial after her guilty verdict on charges of conspiracy and obstruction of justice.
Stewart's conviction centered around her sale of shares in biotech company ImClone, the disposal taking place within hours of that company issuing a statement that its anti-cancer drug Erbitux had been rejected by the Food and Drug Administration.
Her lawyers petitioned for a retrial after accusations that an 'expert witness' had lied while under oath.
Stewart's sentencing is now imminent.
Data sourced from: Financial Times; additional content by WARC staff